ArticleArquivos brasileiros de cardiologia2019
New-Onset Atrial Fibrillation in St-Segment Elevation Myocardial Infarction: Predictors and Impact on Therapy And Mortality.
Article in Arquivos brasileiros de cardiologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 18 citations in OpenAlex.
- Atrial fibrillation and acute myocardial infarction: a Two-Way relationship.Frontiers in cardiovascular medicine · 2026Review
- Association between remnant cholesterol inflammation Index and in-hospital New-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction.Frontiers in cardiovascular medicine · 2026Article
- Plaque, Prodromes, and Personalized Care: A Case Report Reframing Left Main Coronary Artery Occlusion in Females.Cureus · 2025Article
- The monocyte-to-HDL-cholesterol ratio predicts new-onset atrial fibrillation in patients with acute STEMI.Biomarkers in medicine · 2025Article
- Incidence and predictors of new-onset atrial fibrillation in ST-elevation myocardial infarction: A single-center study.Health science reports · 2024Article
- Article
- New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome.Diagnostics (Basel, Switzerland) · 2023Article
- Incidence, clinical predictors, and clinical effect of new-onset atrial fibrillation in myocardial infarction patients: A retrospective cohort study.Saudi medical journal · 2022Article
- Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation.Medicina (Kaunas, Lithuania) · 2022Review
- Impact of kidney function on the occurrence of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction.Anatolian journal of cardiology · 2021Article
- Comprehensive Use of Routine Clinical Parameters to Identify Patients at Risk of New-Onset Atrial Fibrillation in Acute Myocardial Infarction.Journal of clinical medicine · 2021Article
- The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review.Journal of clinical medicine · 2021Review
- Effect of 2 Different Dosages of Rosuvastatin on Prognosis of Acute Myocardial Infarction Patients with New-Onset Atrial Fibrillation in Jinan, China.Medical science monitor : international medical journal of experimental and clinical research · 2020Observational
- Clinical Management of Patients with First-Episode Atrial Fibrillation Detected in the Acute Phase of Myocardial Infarction.Arquivos brasileiros de cardiologia · 2019Article
- New-onset atrial fibrillation after acute coronary syndrome: prevalence and predictive factors.La Tunisie medicaleObservational
Corrections and comments
- Commented on by
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgrundNew-onset atrial fibrillation complicating acute myocardial infarction represents an important challenge, with prognostic significance.
objectiveTo study the incidence, impact on therapy and mortality, and to identify predictors of development of new-onset atrial fibrillation during hospital stay for ST-segment elevation myocardial infarction.
methodsWe studied all patients with ST-elevation myocardial infarction included consecutively, between 2010 and 2017, in a Portuguese national registry and compared two groups: 1 - no atrial fibrillation and 2 - new-onset atrial fibrillation. We adjusted a logistic regression model data analysis to assess the impact of new-onset atrial fibrillation on in-hospital mortality and to identify independent predictors of its development. A p value < 0.05 was considered significant.
resultsWe studied 6325 patients, and new-onset atrial fibrillation was found in 365 (5.8%). Reperfusion was successfully accomplished in both groups with no difference regarding type of reperfusion. In group 2, therapy with beta-blockers and angiotensin-conversion enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs) was less frequent, 20.6% received anticoagulation at discharge and 16.1% were on triple therapy. New-onset atrial fibrillation was associated with more in-hospital complications and mortality. However, it was not found as an independent predictor of in-hospital mortality. We identified age, prior stroke, inferior myocardial infarction and complete atrioventricular block as independent predictors of new-onset atrial fibrillation.
conclusionNew-onset atrial fibrillation remains a frequent complication of myocardial infarction and is associated with higher rate of complications and in-hospital mortality. Age, prior stroke, inferior myocardial infarction and complete atrioventricular block were independent predictors of new onset atrial fibrillation. Only 36.7% of the patients received anticoagulation at discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.